Franck Slowinski

USPTO Granted Patents = 17 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Thieux, FR (2007 - 2012)
Paris, FR (2012)
Le Plessis Robinson, FR (2014)

Company Filing History:

Mitsubishi Pharma Corporation

Mitsubishi Tanabe Pharma Corporation

patents

where one patent can have more than one assignee

Years Active: 2007-2014

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8759343 - Azabicycloalkane derivatives, preparation thereof and use thereof in therapy (2014-06-24),

2. 8173669 - Azabicycloalkane derivatives, preparation thereof and use thereof in therapy (2012-05-08),

3. 8148364 - Substituted bicyclic pyrimidone derivatives (2012-04-03),

4. 8093256 - Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives (2012-01-10),

5. 7781440 - [object Object] (2010-08-24),

6. 7547705 - [object Object] (2009-06-16),

7. 7507743 - Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivatives (2009-03-24),

8. 7462621 - Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agents (2008-12-09),

9. 7452897 - Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases (2008-11-18),

10. 7393853 - [object Object] (2008-07-01),

11. 7388005 - Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders (2008-06-17),

12. 7294632 - Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives (2007-11-13),

13. 7294631 - [object Object] (2007-11-13),

14. 7247638 - 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives. (2007-07-24),

15. 7217715 - Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives (2007-05-15),

Title: Franck Slowinski: Innovator in Azabicycloalkane Derivatives

Introduction

Franck Slowinski is a notable inventor based in Thieux, France. He has made significant contributions to the field of chemistry, particularly in the development of azabicycloalkane derivatives. With a total of 17 patents to his name, Slowinski's work has implications in therapeutic applications.

Latest Patents

Among his latest patents is the invention related to azabicycloalkane derivatives, which includes a method for preparing these compounds and their application in therapy. The compounds are defined by a general formula, wherein specific variables such as R, m, n, and o are outlined. This innovative approach highlights the potential therapeutic uses of these derivatives.

Career Highlights

Throughout his career, Franck Slowinski has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Slowinski has collaborated with esteemed colleagues, including Alistair Lochead and Mourad Saady. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Franck Slowinski's contributions to the field of chemistry, particularly through his patents on azabicycloalkane derivatives, demonstrate his commitment to advancing therapeutic solutions. His work continues to influence the pharmaceutical industry and showcases the importance of innovation in science.

This text is generated by artificial intelligence and may not be accurate.